General contact

Main switchboard
Switzerland

+41 61 324 11 11
+41 61 324 80 01
Monday - Friday,
8:30 a.m. - 5:00 p.m. GMT+1

US switchboard

+1 862 778 21 00
Monday - Friday,
8:30 a.m. - 5:00 p.m. EST

Media

Global Media Relations
Eric Althoff
Basel, Switzerland

+41 61 324 7999

Investors

Investor Relations
Switzerland

Monday - Friday,
8:30 a.m. - 5:30 p.m. GMT+1
(Central European Time)

Reporting side effects

Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.

Reporting side effects

pane 4 content

Positions

We think that in order to find long-term, sustainable solutions to global health challenges, we need to engage in constructive discussions and be transparent about our views. We engage in policy debates, and share the company’s perspective on public health issues, striving for open and constructive interaction.

As part of our ongoing commitment to transparency, we state our position on various issues affecting our business.

Access

R&D

Quality and safety of medicines

Intellectual property

Ethics

Product promotion and marketing

Environment